While the Apple Watch is back on the market, Apple’s patent dispute with medical device company Masimo is far from over. In a new interview with The Wall Street Journal, Masimo CEO Joe Kiani goes ...

Masimo Corp. (NASDAQ:MASI) CEO Joe Kiani thinks Apple Watch users are better off without the blood oxygen monitoring feature now that Apple Inc. (NASDAQ:AAPL) has disabled it on its latest ...

Masimo Corp. Chief Executive Officer Joe Kiani, waging a legal fight with Apple Inc. over a blood oxygen feature, said that consumers are better off without the iPhone maker’s version of the ...

Every time Kelsey publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Joe Kiani has taken on Apple in a patent dispute that has cost his company millions of dollars to pursue. So far he is winning, but the fight isn’t over. Sales have resumed while a court weighs the ...

At a time when the damaging effects of industrial agriculture are becoming more evident, a new approach to farming is emerging. This new model seeks not to deplete the land but to restore it, giving ...

Irvine-based Masimo Corp. Chief Executive Officer Joe Kiani, head of the medical device maker that has put Apple Inc.’s smartwatch on the brink of a US ban, said he’d be open to settling with the ...

Joe Kiani is showing no signs of slowing down despite the challenges he’s faced. He described the past two years as “quite the ordeal.” The medtech entrepreneur has been entangled in a proxy battle ...

However, Masimo's CEO has now explained why the company is in a lawsuit with Apple. He also said that this lawsuit with Apple is a "fight to the end" case. In an interview with the Wall Street Journal ...

Joe Kiani was a 15-year-old Iranian immigrant when he started attending San Diego State University in the 1980s. Before that, he graduated from Valhalla High School in El Cajon. Last month he was ...

Masimo founder Joe Kiani has borrowed against more than half of his $660 million stake in the company rather than sell his shares ahead of an expected proxy fight. Kiani made headlines when Masimo ...